Ochre Bio’s $37.5 Million License Agreement with GSK

Wilson Sonsini Goodrich & Rosati represented Ochre Bio in the transaction.Ochre Bio, a pioneer in chronic liver disease medicine development, announced the start of a multi-year…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here